Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97
2001 · World Journal of Gastroenterology · 390 citations
https://doi.org/10.3748/wjg.v7.i5.630
S
Sheng-Long Ye
Fudan University(CN)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
24
Papers
3.4K
Citations
19
h-index
21
i10-index
Sheng-Long Ye is an academic researcher from Fudan University. The author has contributed to research in topics: Hepatocellular Carcinoma Treatment and Prognosis & Hepatitis B Virus Studies & Hepatitis C virus research. The author has an h-index of 19, co-authored 21 publications.
Papers by this author
worksSafety assessment of sorafenib in Chinese patients with unresectable hepatocellular carcinoma: subgroup analysis of the GIDEON study
2018 · BMC Cancer · 13 citations
https://doi.org/10.1186/s12885-018-4144-9
Eastern asian expert panel opinion: designing clinical trials of molecular targeted therapy for hepatocellular carcinoma
2010 · BMC Cancer · 4 citations
https://doi.org/10.1186/1471-2407-10-620
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat